Ovarian hormones influence corticotropin releasing factor receptor colocalization with delta opioid receptors in CA1 pyramidal cell dendrites

Experimental Neurology

Volumn 230, Issue 2, 2011, Pages 186-196

  Williams, Tanya J ^a,b   Akama, Keith T ^c   Knudsen, Margarete G ^a   Mcewen, Bruce S ^c   Milner, Teresa A ^a,c  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c ROCKEFELLER UNIVERSITY   (United States)

Author keywords

CAMP; Corticotropin releasing hormone; Estrogen; Hippocampus; Hormones; NG108 15; Opioids; SNC80; Stress

Indexed keywords

4 [ALPHA (4 ALLYL 2,5 DIMETHYL 1 PIPERAZINYL) 3 METHOXYBENZYL] N,N DIETHYLBENZAMIDE; CORTICOTROPIN RELEASING FACTOR RECEPTOR; CYCLIC AMP; DELTA OPIATE RECEPTOR; SEX HORMONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL MEMBRANE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; DENDRITE; DENDRITIC SPINE; FEMALE; HIPPOCAMPAL CA1 REGION; HORMONE ACTION; IMMUNOELECTRON MICROSCOPY; IMMUNOGOLD STAINING; IMMUNOREACTIVITY; MALE; NERVE CELL CULTURE; NERVE ENDING; NERVE FIBER; NONHUMAN; PRIORITY JOURNAL; PROESTRUS; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; PYRAMIDAL NERVE CELL; QUANTITATIVE ANALYSIS; RAT; RECEPTOR DENSITY; RECEPTOR OCCUPANCY; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; STRATUM RADIATUM; STRESS;

ANALYSIS OF VARIANCE; ANIMALS; AXONS; CA1 REGION, HIPPOCAMPAL; CELL LINE; CYCLIC AMP; DENDRITES; ESTRADIOL; FEMALE; MALE; MICROSCOPY, IMMUNOELECTRON; PROESTRUS; PYRAMIDAL CELLS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; RECEPTORS, OPIOID, DELTA;

EID: 79958764109     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2011.04.012     Document Type: Article

References (149)

1. Aizawa S., Yamamuro Y. Estradiol regulates alternative splicing of estrogen receptor-alpha mRNA in differentiated NG108-15 neuronal cells. Life Sci. 2008, 82:692-698.
2. Akama K.T., McEwen B.S. Estrogen stimulates postsynaptic density-95 rapid protein synthesis via the Akt/protein kinase B pathway. J. Neurosci. 2003, 23:2333-2339.
3. Aldenhoff J.B., Gruol D.L., Rivier J., Vale W., Siggins G.R. Corticotropin releasing factor decreases postburst hyperpolarizations and excites hippocampal neurons. Science 1983, 221:875-877.
4. Atkins A.L., Mashhoon Y., Kantak K.M. Hippocampal regulation of contextual cue-induced reinstatement of cocaine-seeking behavior. Pharmacol. Biochem. Behav. 2008, 90:481-491.
5. Bangasser D.A., Curtis A., Reyes B.A., Bethea T.T., Parastatidis I., Ischiropoulos H., et al. Sex differences in corticotropin-releasing factor receptor signaling and trafficking: potential role in female vulnerability to stress-related psychopathology. Mol. Psychiatry 2010, 15(877):896-904.
6. Bangasser D.A., Shors T.J. Acute stress impairs trace eye blink conditioning in females without altering the unconditioned response. Neurobiol. Learn. Mem. 2004, 82:57-60.
7. Bangasser D.A., Shors T.J. The hippocampus is necessary for enhancements and impairments of learning following stress. Nat. Neurosci. 2007, 10:1401-1403.
8. Bao G., Kang L., Li H., Li Y., Pu L., Xia P., et al. Morphine and heroin differentially modulate in vivo hippocampal LTP in opiate-dependent rat. Neuropsychopharmacology 2007, 32:1738-1749.
9. Barg J., Levy R., Simantov R. Up-regulation of opiate receptors by opiate antagonists in neuroblastoma-glioma cell culture: the possibility of interaction with guanosine triphosphate-binding proteins. Neurosci. Lett. 1984, 50:133-137.
10. Battaglia G., Webster E.L., De Souza E.B. Characterization of corticotropin-releasing factor receptor-mediated adenylate cyclase activity in the rat central nervous system. Synapse 1987, 1:572-581.
11. Beczkowska I.W., Gracy K.N., Pickel V.M., Inturrisi C.E. Detection of delta opioid receptor and N-methyl-d-aspartate receptor-like immunoreactivity in retinoic acid-differentiated neuroblastoma x glioma (NG108-15) cells. J. Neurosci. Res. 1997, 47:83-89.
12. Belanger A., Cusan L., Caron S., Barden N., Dupont A. Ovarian progestins, androgens and estrogen throughout the 4-day estrous cycle in the rat. Biol. Reprod. 1981, 24:591-596.
13. Bergsbaken C.L., Sommers S.L., Law P.Y. Effect of forskolin and isobutylmethylxanthine on delta-opioid receptor activity in neuroblastoma x glioma NG108-15 cells. J. Pharmacol. Exp. Ther. 1993, 264:1474-1483.
14. Bie B., Zhu W., Pan Z.Z. Rewarding morphine-induced synaptic function of delta-opioid receptors on central glutamate synapses. J. Pharmacol. Exp. Ther. 2009, 329:290-296.
15. Bilsky E.J., Calderon S.N., Wang T., Bernstein R.N., Davis P., Hruby V.J., et al. SNC 80, a selective, nonpeptidic and systemically active opioid delta agonist. J. Pharmacol. Exp. Ther. 1995, 273:359-366.
16. Blank T., Nijholt I., Eckart K., Spiess J. Priming of long-term potentiation in mouse hippocampus by corticotropin-releasing factor and acute stress: implications for hippocampus-dependent learning. J. Neurosci. 2002, 22:3788-3794.
17. Blank T., Nijholt I., Grammatopoulos D.K., Randeva H.S., Hillhouse E.W., Spiess J. Corticotropin-releasing factor receptors couple to multiple G-proteins to activate diverse intracellular signaling pathways in mouse hippocampus: role in neuronal excitability and associative learning. J. Neurosci. 2003, 23:700-707.
18. Bossert J.M., Ghitza U.E., Lu L., Epstein D.H., Shaham Y. Neurobiology of relapse to heroin and cocaine seeking: an update and clinical implications. Eur. J. Pharmacol. 2005, 526:36-50.
19. Bossert J.M., Poles G.C., Wihbey K.A., Koya E., Shaham Y. Differential effects of blockade of dopamine D1-family receptors in nucleus accumbens core or shell on reinstatement of heroin seeking induced by contextual and discrete cues. J. Neurosci. 2007, 27:12655-12663.
20. Bramham C.R., Sarvey J.M. Endogenous activation of mu and delta-1 opioid receptors is required for long-term potentiation induction in the lateral perforant path: dependence on GABAergic inhibition. J. Neurosci. 1996, 16:8123-8131.
21. Brown Z.J., Tribe E., D'souza N.A., Erb S. Interaction between noradrenaline and corticotrophin-releasing factor in the reinstatement of cocaine seeking in the rat. Psychopharmacology (Berl.) 2009, 203:121-130.
22. Brunson K.L., Kramar E., Lin B., Chen Y., Colgin L.L., Yanagihara T.K., et al. Mechanisms of late-onset cognitive decline after early-life stress. J. Neurosci. 2005, 25:9328-9338.
23. Cahill C.M., Holdridge S.V., Morinville A. Trafficking of delta-opioid receptors and other G-protein-coupled receptors: implications for pain and analgesia. Trends Pharmacol. Sci. 2007, 28:23-31.
24. Cahill C.M., Morinville A., Hoffert C., O'Donnell D., Beaudet A. Up-regulation and trafficking of delta opioid receptor in a model of chronic inflammation: implications for pain control. Pain 2003, 101:199-208.
25. Cahill C.M., Morinville A., Lee M.C., Vincent J.P., Collier B., Beaudet A. Prolonged morphine treatment targets delta opioid receptors to neuronal plasma membranes and enhances delta-mediated antinociception. J. Neurosci. 2001, 21:7598-7607.
26. Calderon S.N., Rothman R.B., Porreca F., Flippen-Anderson J.L., McNutt R.W., Xu H., et al. Probes for narcotic receptor mediated phenomena. 19. Synthesis of (+)-4-[(alpha R)-alpha-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]-N, N-diethylbenzamide (SNC 80): a highly selective, nonpeptide delta opioid receptor agonist. J. Med. Chem. 1994, 37:2125-2128.
27. Chan J., Aoki C., Pickel V.M. Optimization of differential immunogold-silver and peroxidase labeling with maintenance of ultrastructure in brain sections before plastic embedding. J. Neurosci. Methods 1990, 33:113-127.
28. Charron C., Frechette S., Proulx G., Plamondon H. In vivo administration of corticotropin-releasing hormone at remote intervals following ischemia enhances CA1 neuronal survival and recovery of spatial memory impairments: a role for opioid receptors. Behav. Brain Res. 2008, 188:125-135.
29. Charron C., Messier C., Plamondon H. Neuroprotection and functional recovery conferred by administration of kappa- and delta 1-opioid agonists in a rat model of global ischemia. Physiol. Behav. 2008, 93:502-511.
30. Charron C., Schock S.C., Proulx G., Thompson C.S., Hakim A.M., Plamondon H. Protection conferred by corticotropin-releasing hormone in rat primary cortical neurons against chemical ischemia involves opioid receptor activation. Brain Res. 2009, 1257:117-127.
31. Chen F.M., Bilezikjian L.M., Perrin M.H., Rivier J., Vale W. Corticotropin releasing factor receptor-mediated stimulation of adenylate cyclase activity in the rat brain. Brain Res. 1986, 381:49-57.
32. Chen Y., Brunson K.L., Adelmann G., Bender R.A., Frotscher M., Baram T.Z. Hippocampal corticotropin releasing hormone: pre- and postsynaptic location and release by stress. Neuroscience 2004, 126:533-540.
33. Chen Y., Brunson K.L., Muller M.B., Cariaga W., Baram T.Z. Immunocytochemical distribution of corticotropin-releasing hormone receptor type-1 (CRF(1))-like immunoreactivity in the mouse brain: light microscopy analysis using an antibody directed against the C-terminus. J. Comp. Neurol. 2000, 420:305-323.
34. Chen Y., Dube C.M., Rice C.J., Baram T.Z. Rapid loss of dendritic spines after stress involves derangement of spine dynamics by corticotropin-releasing hormone. J. Neurosci. 2008, 28:2903-2911.
35. Chen Y., Fenoglio K.A., Dube C.M., Grigoriadis D.E., Baram T.Z. Cellular and molecular mechanisms of hippocampal activation by acute stress are age-dependent. Mol. Psychiatry 2006, 11:992-1002.
36. Cheng P.Y., Svingos A.L., Wang H., Clarke C.L., Jenab S., Beczkowska I.W., et al. Ultrastructural immunolabeling shows prominent presynaptic vesicular localization of delta-opioid receptor within both enkephalin- and nonenkephalin-containing axon terminals in the superficial layers of the rat cervical spinal cord. J. Neurosci. 1995, 15:5976-5988.
37. Ciccocioppo R., Martin-Fardon R., Weiss F. Effect of selective blockade of mu(1) or delta opioid receptors on reinstatement of alcohol-seeking behavior by drug-associated stimuli in rats. Neuropsychopharmacology 2002, 27:391-399.
38. Commons K.G. Translocation of presynaptic delta opioid receptors in the ventrolateral periaqueductal gray after swim stress. J. Comp. Neurol. 2003, 464:197-207.
39. Commons K.G., Milner T.A. Cellular and subcellular localization of delta opioid receptor immunoreactivity in the rat dentate gyrus. Brain Res. 1996, 738:181-195.
40. Commons K.G., Milner T.A. Localization of delta opioid receptor immunoreactivity in interneurons and pyramidal cells in the rat hippocampus. J. Comp. Neurol. 1997, 381:373-387.
41. Cooke B.M., Woolley C.S. Gonadal hormone modulation of dendrites in the mammalian CNS. J. Neurobiol. 2005, 64:34-46.
42. Crombag H.S., Bossert J.M., Koya E., Shaham Y. Review. Context-induced relapse to drug seeking: a review. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2008, 363:3233-3243.
43. Curtis A.L., Bethea T., Valentino R.J. Sexually dimorphic responses of the brain norepinephrine system to stress and corticotropin-releasing factor. Neuropsychopharmacology 2006, 31:544-554.
44. Dalla C., Whetstone A.S., Hodes G.E., Shors T.J. Stressful experience has opposite effects on dendritic spines in the hippocampus of cycling versus masculinized females. Neurosci. Lett. 2009, 449:52-56.
45. De Souza E.B. Corticotropin-releasing factor receptors: physiology, pharmacology, biochemistry and role in central nervous system and immune disorders. Psychoneuroendocrinology 1995, 20:789-819.
46. Drake C.T., Chavkin C., Milner T.A. Opioid systems in the dentate gyrus. Prog. Brain Res. 2007, 163:245-263.
47. Drake C.T., Milner T.A. Mu opioid receptors are in somatodendritic and axonal compartments of GABAergic neurons in rat hippocampal formation. Brain Res. 1999, 849:203-215.
48. Drake C.T., Milner T.A. Mu opioid receptors are in discrete hippocampal interneuron subpopulations. Hippocampus 2002, 12:119-136.
49. Eckart K., Jahn O., Radulovic J., Radulovic M., Blank T., Stiedl O., et al. Pharmacology and biology of corticotropin-releasing factor (CRF) receptors. Receptors Channels 2002, 8:163-177.
50. Elliott-Hunt C.R., Kazlauskaite J., Wilde G.J., Grammatopoulos D.K., Hillhouse E.W. Potential signalling pathways underlying corticotrophin-releasing hormone-mediated neuroprotection from excitotoxicity in rat hippocampus. J. Neurochem. 2002, 80:416-425.
51. Elman I., Karlsgodt K.H., Gastfriend D.R. Gender differences in cocaine craving among non-treatment-seeking individuals with cocaine dependence. Am. J. Drug Alcohol Abuse 2001, 27:193-202.
52. Feng Y., Chao D., He X., Yang Y., Kang X., Lazarus L.H., et al. A novel insight into neuroprotection against hypoxic/ischemic stress. Sheng Li Xue Bao 2009, 61:585-592.
53. Fuchs R.A., Eaddy J.L., Su Z.I., Bell G.H. Interactions of the basolateral amygdala with the dorsal hippocampus and dorsomedial prefrontal cortex regulate drug context-induced reinstatement of cocaine-seeking in rats. Eur. J. Neurosci. 2007, 26:487-498.
54. Fuchs R.A., Evans K.A., Ledford C.C., Parker M.P., Case J.M., Mehta R.H., et al. The role of the dorsomedial prefrontal cortex, basolateral amygdala, and dorsal hippocampus in contextual reinstatement of cocaine seeking in rats. Neuropsychopharmacology 2005, 30:296-309.
55. Gallagher J.P., Orozco-Cabal L.F., Liu J., Shinnick-Gallagher P. Synaptic physiology of central CRH system. Eur. J. Pharmacol. 2008, 583:215-225.
56. Gao C.J., Li J.P., Wang W., Lu B.C., Niu L., Zhu C., et al. Effects of intracerebroventricular application of the delta opioid receptor agonist [D-Ala2, D-Leu5] enkephalin on neurological recovery following asphyxial cardiac arrest in rats. Neuroscience 2010, 168:531-542.
57. George S.R., Zastawny R.L., Briones-Urbina R., Cheng R., Nguyen T., Heiber M., et al. Distinct distributions of mu, delta and kappa opioid receptor mRNA in rat brain. Biochem. Biophys. Res. Commun. 1994, 205:1438-1444.
58. Gould E., Woolley C.S., Frankfurt M., McEwen B.S. Gonadal steroids regulate dendritic spine density in hippocampal pyramidal cells in adulthood. J. Neurosci. 1990, 10:1286-1291.
59. Grammatopoulos D.K., Randeva H.S., Levine M.A., Kanellopoulou K.A., Hillhouse E.W. Rat cerebral cortex corticotropin-releasing hormone receptors: evidence for receptor coupling to multiple G-proteins. J. Neurochem. 2001, 76:509-519.
60. Hamprecht B., Glaser T., Reiser G., Bayer E., Propst F. Culture and characteristics of hormone-responsive neuroblastoma X glioma hybrid cells. Methods Enzymol. 1985, 109:316-341.
61. Harris K.M., Jensen F.E., Tsao B. Three-dimensional structure of dendritic spines and synapses in rat hippocampus (CA1) at postnatal day 15 and adult ages: implications for the maturation of synaptic physiology and long-term potentiation. J. Neurosci. 1992, 12:2685-2705.
62. Hayashi T., Tsao L.I., Su T.P. Antiapoptotic and cytotoxic properties of delta opioid peptide [D-Ala(2), D-Leu(5)]enkephalin in PC12 cells. Synapse 2002, 43:86-94.
63. Hermann H., Lutz B. Coexpression of the cannabinoid receptor type 1 with the corticotropin-releasing hormone receptor type 1 in distinct regions of the adult mouse forebrain. Neurosci. Lett. 2005, 375:13-18.
64. Hillhouse E.W., Grammatopoulos D.K. The molecular mechanisms underlying the regulation of the biological activity of corticotropin-releasing hormone receptors: implications for physiology and pathophysiology. Endocr. Rev. 2006, 27:260-286.
65. Hollrigel G.S., Chen K., Baram T.Z., Soltesz I. The pro-convulsant actions of corticotropin-releasing hormone in the hippocampus of infant rats. Neuroscience 1998, 84:71-79.
66. Hsu S.M., Raine L., Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J. Histochem. Cytochem. 1981, 29:577-580.
67. Johnson S.M., Turner S.M. Protecting motor networks during perinatal ischemia: the case for delta-opioid receptors. Ann. N. Y. Acad. Sci. 2010, 1198:260-270.
68. Justice N.J., Yuan Z.F., Sawchenko P.E., Vale W. Type 1 corticotropin-releasing factor receptor expression reported in BAC transgenic mice: implications for reconciling ligand-receptor mismatch in the central corticotropin-releasing factor system. J. Comp. Neurol. 2008, 511:479-496.
69. Kessler R.C., McGonagle K.A., Swartz M., Blazer D.G., Nelson C.B. Sex and depression in the National Comorbidity Survey. I: Lifetime prevalence, chronicity and recurrence. J. Affect. Disord. 1993, 29:85-96.
70. Kessler R.C., Sonnega A., Bromet E., Hughes M., Nelson C.B. Posttraumatic stress disorder in the National Comorbidity Survey. Arch. Gen. Psychiatry 1995, 52:1048-1060.
71. Kieffer B.L., Befort K., Gaveriaux-Ruff C., Hirth C.G. The delta-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization. Proc. Natl Acad. Sci. U. S. A. 1992, 89:12048-12052.
72. Kilts C.D., Schweitzer J.B., Quinn C.K., Gross R.E., Faber T.L., Muhammad F., et al. Neural activity related to drug craving in cocaine addiction. Arch. Gen. Psychiatry 2001, 58:334-341.
73. Kotlinska J.H., Gibula-Bruzda E., Pachuta A., Kunce D., Witkowska E., Chung N.N., et al. Influence of new deltorphin analogues on reinstatement of cocaine-induced conditioned place preference in rats. Behav. Pharmacol. 2010, 21:638-648.
74. Leranth C., Pickel V.M. Electron microscopic preembedding double-labeling methods. Neuroanatomical Tract-Tracing Methods 1989, 2:129-172. Plenum Press, New York. L. Heimer, L. Zaborszky (Eds.).
75. Leuner B., Shors T.J. New spines, new memories. Mol. Neurobiol. 2004, 29:117-130.
76. Luine V.N., Beck K.D., Bowman R.E., Frankfurt M., Maclusky N.J. Chronic stress and neural function: accounting for sex and age. J. Neuroendocrinol. 2007, 19:743-751.
77. Lujan R., Nusser Z., Roberts J.D., Shigemoto R., Somogyi P. Perisynaptic location of metabotropic glutamate receptors mGluR1 and mGluR5 on dendrites and dendritic spines in the rat hippocampus. Eur. J. Neurosci. 1996, 8:1488-1500.
78. Ma J., Zhang Y., Kalyuzhny A.E., Pan Z.Z. Emergence of functional delta-opioid receptors induced by long-term treatment with morphine. Mol. Pharmacol. 2006, 69:1137-1145.
79. Ma M.C., Qian H., Ghassemi F., Zhao P., Xia Y. Oxygen-sensitive {delta}-opioid receptor-regulated survival and death signals: novel insights into neuronal preconditioning and protection. J. Biol. Chem. 2005, 280:16208-16218.
80. Maletic-Savatic M., Malinow R., Svoboda K. Rapid dendritic morphogenesis in CA1 hippocampal dendrites induced by synaptic activity. Science 1999, 283:1923-1927.
81. Marcondes F.K., Bianchi F.J., Tanno A.P. Determination of the estrous cycle phases of rats: some helpful considerations. Braz. J. Biol. 2002, 62:609-614.
82. Marcus S.M., Kerber K.B., Rush A.J., Wisniewski S.R., Nierenberg A., Balasubramani G.K., et al. Sex differences in depression symptoms in treatment-seeking adults: confirmatory analyses from the Sequenced Treatment Alternatives to Relieve Depression study. Compr. Psychiatry 2008, 49:238-246.
83. Marcus S.M., Young E.A., Kerber K.B., Kornstein S., Farabaugh A.H., Mitchell J., et al. Gender differences in depression: findings from the STAR*D study. J. Affect. Disord. 2005, 87:141-150.
84. Marinelli P.W., Funk D., Harding S., Li Z., Juzytsch W., Le A.D. Roles of opioid receptor subtypes in mediating alcohol-seeking induced by discrete cues and context. Eur. J. Neurosci. 2009, 30:671-678.
85. Marinelli P.W., Funk D., Juzytsch W., Li Z., Le A.D. Effects of opioid receptor blockade on the renewal of alcohol seeking induced by context: relationship to c-fos mRNA expression. Eur. J. Neurosci. 2007, 26:2815-2823.
86. McCarthy M.M., Konkle A.T. When is a sex difference not a sex difference?. Front. Neuroendocrinol. 2005, 26:85-102.
87. McEwen B.S., Milner T.A. Hippocampal formation: shedding light on the influence of sex and stress on the brain. Brain Res. Rev. 2007, 55:343-355.
88. McKay J.R., Rutherford M.J., Cacciola J.S., Kabasakalian-McKay R., Alterman A.I. Gender differences in the relapse experiences of cocaine patients. J. Nerv. Ment. Dis. 1996, 184:616-622.
89. McLaughlin K.J., Baran S.E., Conrad C.D. Chronic stress- and sex-specific neuromorphological and functional changes in limbic structures. Mol. Neurobiol. 2009, 40:166-182.
90. McLaughlin K.J., Baran S.E., Wright R.L., Conrad C.D. Chronic stress enhances spatial memory in ovariectomized female rats despite CA3 dendritic retraction: possible involvement of CA1 neurons. Neuroscience 2005, 135:1045-1054.
91. Milner T.A., McEwen B.S., Hayashi S., Li C.J., Reagan L.P., Alves S.E. Ultrastructural evidence that hippocampal alpha estrogen receptors are located at extranuclear sites. J. Comp. Neurol. 2001, 429:355-371.
92. Milner T.A., Veznedaroglu E. Ultrastructural localization of neuropeptide Y-like immunoreactivity in the rat hippocampal formation. Hippocampus 1992, 2:107-125.
93. Narita M., Kuzumaki N., Miyatake M., Sato F., Wachi H., Seyama Y., et al. Role of delta-opioid receptor function in neurogenesis and neuroprotection. J. Neurochem. 2006, 97:1494-1505.
94. O'Brien C.P., Childress A.R., Ehrman R., Robbins S.J. Conditioning factors in drug abuse: can they explain compulsion?. J. Psychopharmacol. 1998, 12:15-22.
95. Parducz A., Hajszan T., Maclusky N.J., Hoyk Z., Csakvari E., Kurunczi A., et al. Synaptic remodeling induced by gonadal hormones: neuronal plasticity as a mediator of neuroendocrine and behavioral responses to steroids. Neuroscience 2006, 138:977-985.
96. Pedersen W.A., Wan R., Zhang P., Mattson M.P. Urocortin, but not urocortin II, protects cultured hippocampal neurons from oxidative and excitotoxic cell death via corticotropin-releasing hormone receptor type I. J. Neurosci. 2002, 22:404-412.
97. Persson A.I., Thorlin T., Eriksson P.S. Comparison of immunoblotted delta opioid receptor proteins expressed in the adult rat brain and their regulation by growth hormone. Neurosci. Res. 2005, 52:1-9.
98. Persson P.A., Thorlin T., Ronnback L., Hansson E., Eriksson P.S. Differential expression of delta opioid receptors and mRNA in proliferating astrocytes during the cell cycle. J. Neurosci. Res. 2000, 61:371-375.
99. Peters A., Palay S.L., Webster H.D. The Fine Structure of the Nervous System 1991, Oxford University Press, New York.
100. Pierce J.P., Kurucz O.S., Milner T.A. Morphometry of a peptidergic transmitter system: dynorphin B-like immunoreactivity in the rat hippocampal mossy fiber pathway before and after seizures. Hippocampus 1999, 9:255-276.
101. Piguet P., North R.A. Opioid actions at mu and delta receptors in the rat dentate gyrus in vitro. J. Pharmacol. Exp. Ther. 1993, 266:1139-1149.
102. Pradhan A.A., Becker J.A., Scherrer G., Tryoen-Toth P., Filliol D., Matifas A., et al. In vivo delta opioid receptor internalization controls behavioral effects of agonists. PLoS One 2009, 4:e5425.
103. Quock R.M., Burkey T.H., Varga E., Hosohata Y., Hosohata K., Cowell S.M., et al. The delta-opioid receptor: molecular pharmacology, signal transduction, and the determination of drug efficacy. Pharmacol. Rev. 1999, 51:503-532.
104. Reyes B.A., Fox K., Valentino R.J., Van Bockstaele E.J. Agonist-induced internalization of corticotropin-releasing factor receptors in noradrenergic neurons of the rat locus coeruleus. Eur. J. Neurosci. 2006, 23:2991-2998.
105. Reyes B.A., Valentino R.J., Van Bockstaele E.J. Stress-induced intracellular trafficking of corticotropin-releasing factor receptors in rat locus coeruleus neurons. Endocrinology 2008, 149:122-130.
106. Risinger R.C., Salmeron B.J., Ross T.J., Amen S.L., Sanfilipo M., Hoffmann R.G., et al. Neural correlates of high and craving during cocaine self-administration using BOLD fMRI. Neuroimage 2005, 26:1097-1108.
107. Roe S.Y., McGowan E.M., Rothwell N.J. Evidence for the involvement of corticotrophin-releasing hormone in the pathogenesis of traumatic brain injury. Eur. J. Neurosci. 1998, 10:553-559.
108. Rogers J.L., Ghee S., See R.E. The neural circuitry underlying reinstatement of heroin-seeking behavior in an animal model of relapse. Neuroscience 2008, 151:579-588.
109. Rubin A., Stout R.L., Longabaugh R. Gender differences in relapse situations. Addiction 1996, 91:S111-S120. Suppl.
110. Saal D., Dong Y., Bonci A., Malenka R.C. Drugs of abuse and stress trigger a common synaptic adaptation in dopamine neurons. Neuron 2003, 37:577-582.
111. Saland L.C., Hastings C.M., Abeyta A., Chavez J.B. Chronic ethanol modulates delta and mu-opioid receptor expression in rat CNS: immunohistochemical analysis with quantitative confocal microscopy. Neurosci. Lett. 2005, 381:163-168.
112. Sananbenesi F., Fischer A., Schrick C., Spiess J., Radulovic J. Mitogen-activated protein kinase signaling in the hippocampus and its modulation by corticotropin-releasing factor receptor 2: a possible link between stress and fear memory. J. Neurosci. 2003, 23:11436-11443.
113. Sauvage M., Steckler T. Detection of corticotropin-releasing hormone receptor 1 immunoreactivity in cholinergic, dopaminergic and noradrenergic neurons of the murine basal forebrain and brainstem nuclei-potential implication for arousal and attention. Neuroscience 2001, 104:643-652.
114. Schierloh A., Deussing J., Wurst W., Zieglgansberger W., Rammes G. Corticotropin-releasing factor (CRF) receptor type 1-dependent modulation of synaptic plasticity. Neurosci. Lett. 2007, 416:82-86.
115. Schneider F., Habel U., Wagner M., Franke P., Salloum J.B., Shah N.J., et al. Subcortical correlates of craving in recently abstinent alcoholic patients. Am. J. Psychiatry 2001, 158:1075-1083.
116. Segal M. Dendritic spines and long-term plasticity. Nat. Rev. Neurosci. 2005, 6:277-284.
117. Servatius R.J., Shors T.J. Exposure to inescapable stress persistently facilitates associative and nonassociative learning in rats. Behav. Neurosci. 1994, 108:1101-1106.
118. Shaham Y., Erb S., Stewart J. Stress-induced relapse to heroin and cocaine seeking in rats: a review. Brain Res. Brain Res. Rev. 2000, 33:13-33.
119. Shaham Y., Funk D., Erb S., Brown T.J., Walker C.D., Stewart J. Corticotropin-releasing factor, but not corticosterone, is involved in stress-induced relapse to heroin-seeking in rats. J. Neurosci. 1997, 17:2605-2614.
120. Shalev U., Erb S., Shaham Y. Role of CRF and other neuropeptides in stress-induced reinstatement of drug seeking. Brain Res. 2010, 1314:15-28.
121. Sheng H., Zhang Y., Sun J., Gao L., Ma B., Lu J., et al. Corticotropin-releasing hormone (CRH) depresses N-methyl-d-aspartate receptor-mediated current in cultured rat hippocampal neurons via CRH receptor type 1. Endocrinology 2008, 149:1389-1398.
122. Shors T.J., Chua C., Falduto J. Sex differences and opposite effects of stress on dendritic spine density in the male versus female hippocampus. J. Neurosci. 2001, 21:6292-6297.
123. Shors T.J., Lewczyk C., Pacynski M., Mathew P.R., Pickett J. Stages of estrous mediate the stress-induced impairment of associative learning in the female rat. Neuroreport 1998, 9:419-423.
124. Shors T.J., Servatius R.J. The contribution of stressor intensity, duration, and context to the stress-induced facilitation of associative learning. Neurobiol. Learn. Mem. 1997, 68:92-96.
125. Sinha R. The role of stress in addiction relapse. Curr. Psychiatry Rep. 2007, 9:388-395.
126. Spencer J.L., Waters E.M., Milner T.A., McEwen B.S. Estrous cycle regulates activation of hippocampal Akt, LIM kinase, and neurotrophin receptors in C57BL/6 mice. Neuroscience 2008, 155:1106-1119.
127. Stewart J. Stress and relapse to drug seeking: studies in laboratory animals shed light on mechanisms and sources of long-term vulnerability. Am. J. Addict. 2003, 12:1-17.
128. Stumm R.K., Zhou C., Schulz S., Hollt V. Neuronal types expressing mu- and delta-opioid receptor mRNA in the rat hippocampal formation. J. Comp. Neurol. 2004, 469:107-118.
129. Svingos A.L., Cheng P.Y., Clarke C.L., Pickel V.M. Ultrastructural localization of delta-opioid receptor and Met5-enkephalin immunoreactivity in rat insular cortex. Brain Res. 1995, 700:25-39.
130. Svoboda K.R., Adams C.E., Lupica C.R. Opioid receptor subtype expression defines morphologically distinct classes of hippocampal interneurons. J. Neurosci. 1999, 19:85-95.
131. Swanson L.W. Brain Maps: Structure of the Rat Brain 2000, Academic Press, San Diego, CA. 2nd ed.
132. Torres-Reveron A., Khalid S., Williams T.J., Waters E.M., Drake C.T., McEwen B.S., et al. Ovarian steroids modulate leu-enkephalin levels and target leu-enkephalinergic profiles in the female hippocampal mossy fiber pathway. Brain Res. 2008, 1232:70-84.
133. Torres-Reveron A., Khalid S., Williams T.J., Waters E.M., Jacome L., Luine V.N., et al. Hippocampal dynorphin immunoreactivity increases in response to gonadal steroids and is positioned for direct modulation by ovarian steroid receptors. Neuroscience 2009, 159:204-216.
134. Torres-Reveron A., Williams T.J., Chapleau J.D., Waters E.M., McEwen B.S., Drake C.T., et al. Ovarian steroids alter mu opioid receptor trafficking in hippocampal parvalbumin GABAergic interneurons. Exp. Neurol. 2009, 219:319-327.
135. Towart L.A., Alves S.E., Znamensky V., Hayashi S., McEwen B.S., Milner T.A. Subcellular relationships between cholinergic terminals and estrogen receptor-alpha in the dorsal hippocampus. J. Comp. Neurol. 2003, 463:390-401.
136. Turner C.D., Bagnara J.T. General Endocrinology 1971, W.B. Saunders, Philadelphia.
137. Valentino R.J., Van Bockstaele E. Convergent regulation of locus coeruleus activity as an adaptive response to stress. Eur. J. Pharmacol. 2008, 583:194-203.
138. Van Bockstaele E.J., Reyes B.A., Valentino R.J. The locus coeruleus: a key nucleus where stress and opioids intersect to mediate vulnerability to opiate abuse. Brain Res. 2010, 1314:162-174.
139. Van P.K., Viau V., Bittencourt J.C., Chan R.K., Li H.Y., Arias C., et al. Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse. J. Comp. Neurol. 2000, 428:191-212.
140. Wang H.L., Tsai L.Y., Lee E.H. Corticotropin-releasing factor produces a protein synthesis-dependent long-lasting potentiation in dentate gyrus neurons. J. Neurophysiol. 2000, 83:343-349.
141. Wang H.L., Wayner M.J., Chai C.Y., Lee E.H. Corticotrophin-releasing factor produces a long-lasting enhancement of synaptic efficacy in the hippocampus. Eur. J. Neurosci. 1998, 10:3428-3437.
142. Waselus M., Nazzaro C., Valentino R.J., Van Bockstaele E.J. Stress-induced redistribution of corticotropin-releasing factor receptor subtypes in the dorsal raphe nucleus. Biol. Psychiatry 2009, 66:76-83.
143. Williams T.J., Torres-Reveron A., Chapleau J.D., Milner T.A. Hormonal regulation of delta opioid receptor immunoreactivity in interneurons and pyramidal cells in the rat hippocampus. Neurobiol. Learn. Mem. 2011, 95:206-220.
144. Wilson M.A., Mascagni F., McDonald A.J. Sex differences in delta opioid receptor immunoreactivity in rat medial amygdala. Neurosci. Lett. 2002, 328:160-164.
145. Woolley C.S., Gould E., Frankfurt M., McEwen B.S. Naturally occurring fluctuation in dendritic spine density on adult hippocampal pyramidal neurons. J. Neurosci. 1990, 10:4035-4039.
146. Woolley C.S., McEwen B.S. Estradiol mediates fluctuation in hippocampal synapse density during the estrous cycle in the adult rat. J. Neurosci. 1992, 12:2549-2554.
147. Yano S., Tokumitsu H., Soderling T.R. Calcium promotes cell survival through CaM-K kinase activation of the protein-kinase-B pathway. Nature 1998, 396:584-587.
148. Young S.F., Griffante C., Aguilera G. Dimerization between vasopressin V1b and corticotropin releasing hormone type 1 receptors. Cell. Mol. Neurobiol. 2007, 27:439-461.
149. Znamensky V., Akama K.T., McEwen B.S., Milner T.A. Estrogen levels regulate the subcellular distribution of phosphorylated Akt in hippocampal CA1 dendrites. J. Neurosci. 2003, 23:2340-2347.